Sutimlimab ( designated) this experimental agent is a targeted biologic with a identification code of 2049079-64-1 . It operates by directly neutralizing complement component 5 , a fragment within https://gorillasocialwork.com/story27003451/sutimlimab-the-deep-examination-into-the-compound-protein